【打印本页】 【下载PDF全文】 【HTML】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 2258次   下载 2206 本文二维码信息
码上扫一扫!
稳定微管减少心肌缺血再灌注损伤
冯健,吴丁烨,尤华彦,李坚,王强,曹华明*
0
(南京医科大学附属无锡市人民医院心内科,无锡 214023)
摘要:
目的 探讨稳定微管能否减少心肌缺血再灌注损伤。方法 (1)将离体大鼠心脏分为对照组、缺血组、缺血+0.1 μmol/L泰素和缺血+1 μmol/L泰素组(n=15)。每组先给予15 min平衡后,对照组继续给予50 min常氧灌注;缺血组给予20 min常氧灌注+30 min缺血处理;缺血+0.1 μmol/L(或1 μmol/L)泰素组给予20 min常氧灌注,30 min缺血处理,整个过程中均给予0.1 μmol/L(或1 μmol/L)泰素灌流。比较各组心律失常情况,观察微管形态结构并进行断裂评分。(2)将离体大鼠心脏分为正常对照组、缺血再灌注组和1 μmol/L泰素组(n=8)。缺血再灌注组进行Langendorff灌流,结扎左前降支30 min,再灌注120 min;1 μmol/L泰素组给予1 μmol/L进行灌流,其余处理同缺血再灌注组。灌流结束即刻冠脉内灌入伊文思蓝进行染色,比较各组心肌梗死面积。结果 (1)0.1和1 μmol/L泰素均能有效降低缺血性室性心律失常的发生,降低室性心律失常评分,且呈剂量依赖性(P<0.05);并均能降低室性心动过速的发生率(P<0.05)。(2)0.1 μmol/L泰素灌流能降低微管断裂评分。(3)1 μmol/L泰素灌流能明显缩小缺血再灌注心脏梗死区面积(P<0.05)。结论 稳定微管能减少心肌缺血再灌注损伤。
关键词:  泰素  微管  缺血性室性心律失常  心肌梗死  再灌注损伤
DOI:10.3724/SP.J.1008.2013.00167
投稿时间:2012-10-25修订日期:2012-12-31
基金项目:无锡市科技局医学技术重大项目(YGZ1104).
Experimental research on stabilizing microtubules to decrease myocardial injury
FENG Jian,WU Ding-ye,YOU Hua-yan,LI Jian,WANG Qiang,CAO Hua-ming*
(Department of Cardiology, Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi 213023, Jiangsu, China
*Corresponding author.)
Abstract:
Objective To study whether stabilizing microtubules can decrease myocardial ischaemic-reperfusion injury. Methods (1) The isolated rat hearts were divided into four groups (n=15): control group, ischemic group, ischemic+0.1 μmol/L Taxol group, and ischemic+1 μmol/L Taxol group. All the groups were given a 15-min equilibration and then followed by different treatments: control group, 50 min normoxic superfusion; ischemia group, 20 min normoxic superfusion plus 30 min ischemia; and Taxol groups, 20 min normoxic superfusion plus 30 min ischemia, plus 0.1 or 1 μmol/L Taxol throughout 50-min superfusion period. Arrthymias scores were assessed and compared between different groups; the structure of the microtubules was observed and its breakage score was obtained. (2) The isolated rat hearts were divided into 3 groups (n=8): normal control group, ischemic/reperfusion (I/R) group, and 1 μmol/L Taxol group. The I/R group was Langendorff-perfused; the left anterior descending branch was ligated for 30 min and reperfused for 120 min. The Taxol group received 1 μmol/L Taxol and other treatments were similar to the I/R group. Evans blue perfusion was used to observe the infarct size of each group. Results Stabilizing microtubules with Taxol (0.1 μmol/L or 1 μmol/L) reduced ischaemic ventricular arrhythmia in a dose-dependent fashion (P<0.05); it also significantly reduced arrhythmia scores and the incidence of ventricular tachycardia (P<0.05). Taxol at 0.1 μmol/L greatly decreased microtubule breakage score, and at 1 μmol/L significantly reduced the infarct size compared with the control group (P<0.05). Conclusion Stabilizing microtubules can reduce myocardial ischaemic-reperfusion injury.
Key words:  Taxol  microtubules  ischaemic ventricular arrhythmia  myocardial infarction  reperfusion injury